CAMK4 and autosomal dominant polycystic kidney disease: To determine whether CaMK4 inhibition and AMPK activation can exhibit an additive inhibitory effect on mTOR signaling, we treated ADPKD cells with 1 μM KN-93, 0.1 mM metformin, or a combination of both.